Related Experiment Videos
Vasopressors in obstetrics: what should we be using?
Warwick D Ngan Kee1, Kim S Khaw
1Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital Shatin, Hong Kong, China. warwick@cuhk.edu.hk
Current Opinion in Anaesthesiology
|June 1, 2006
Summary
Phenylephrine is now considered the optimal vasopressor for obstetric anesthesia, particularly for cesarean sections. It offers better efficacy and titration than ephedrine, with improved fetal outcomes.
Area of Science:
- Obstetric Anesthesiology
- Pharmacology
- Maternal-Fetal Medicine
Background:
- Historically, ephedrine was favored in obstetrics due to perceived lower uterine blood flow reduction.
- Recent clinical data challenge this notion, emphasizing the need to re-evaluate vasopressor choices.
- Spinal anesthesia for cesarean section is a key focus for vasopressor management.
Purpose of the Study:
- To review current evidence on vasopressor use in obstetric anesthesia.
- To compare ephedrine and phenylephrine efficacy and safety profiles.
- To determine the optimal vasopressor for cesarean delivery under spinal anesthesia.
Main Methods:
- Systematic review of clinical studies comparing ephedrine and phenylephrine.
- Analysis of maternal and fetal hemodynamic effects.
- Evaluation of titration ease and adverse event profiles.
Main Results:
- Ephedrine has limited efficacy, causes tachycardia, and can depress fetal pH.
- Phenylephrine demonstrates high efficacy, easy titration, and prevents fetal acidosis.
- Phenylephrine may reduce maternal heart rate and cardiac output; data in high-risk cases are limited.
- A combination of phenylephrine infusion and crystalloid cohydration effectively prevents hypotension.
Conclusions:
- Phenylephrine emerges as the preferred vasopressor in obstetrics.
- It offers superior efficacy and safety compared to ephedrine for cesarean delivery.
- Further research is needed for phenylephrine use in high-risk obstetric patients.